Literature DB >> 26562149

Renal Integrin-Linked Kinase Depletion Induces Kidney cGMP-Axis Upregulation: Consequences on Basal and Acutely Damaged Renal Function.

José Luis Cano-Peñalver1,2, Mercedes Griera1,2, Andrea García-Jerez1,2, Marco Hatem-Vaquero1,2, María Piedad Ruiz-Torres1,2, Diego Rodríguez-Puyol2,3, Sergio de Frutos1,2, Manuel Rodríguez-Puyol1,2.   

Abstract

Soluble guanylyl cyclase (sGC) is activated by nitric oxide (NO) and produces cGMP, which activates cGMP-dependent protein kinases (PKG) and is hydrolyzed by specific phosphodiesterases (PDE). The vasodilatory and cytoprotective capacity of cGMP-axis activation results in a therapeutic strategy for several pathologies. Integrin-linked kinase (ILK), a major scaffold protein between the extracellular matrix and intracellular signaling pathways, may modulate the expression and functionality of the cGMP-axis-related proteins. We introduce ILK as a novel modulator in renal homeostasis as well as a potential target for cisplatin (CIS)-induced acute kidney injury (AKI) improvement. We used an adult mice model of depletion of ILK (cKD-ILK), which showed basal increase of sGC and PKG expressions and activities in renal cortex when compared with wildtype (WT) littermates. Twenty-four h activation of sGC activation with NO enhanced the filtration rate in cKD-ILK. During AKI, cKD-ILK maintained the cGMP-axis upregulation with consequent filtration rates enhancement and ameliorated CIS-dependent tubular epithelial-to-mesenchymal transition and inflammation and markers. To emphasize the role of cGMP-axis upregulation due to ILK depletion, we modulated the cGMP axis under AKI in vivo and in renal cultured cells. A suboptimal dose of the PDE inhibitor ZAP enhanced the beneficial effects of the ILK depletion in AKI mice. On the other hand, CIS increased contractility-related events in cultured glomerular mesangial cells and necrosis rates in cultured tubular cells; ILK depletion protected the cells while sGC blockade with ODQ fully recovered the damage.

Entities:  

Year:  2015        PMID: 26562149      PMCID: PMC4818263          DOI: 10.2119/molmed.2015.00059

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  53 in total

1.  Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin.

Authors:  K Irie; E Fujii; H Ishida; K Wada; T Suganuma; T Nishikori; T Yoshioka; T Muraki
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.

Authors:  Young Sun Kang; Yingjian Li; Chunsun Dai; Lawrence P Kiss; Chuanyue Wu; Youhua Liu
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

Review 3.  Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.

Authors:  T P Dousa
Journal:  Kidney Int       Date:  1999-01       Impact factor: 10.612

4.  Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen.

Authors:  L González-Santiago; S López-Ongil; M Rodríguez-Puyol; D Rodríguez-Puyol
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

Review 5.  Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update.

Authors:  Neife Aparecida Guinaim dos Santos; Maria Augusta Carvalho Rodrigues; Nadia Maria Martins; Antonio Cardozo dos Santos
Journal:  Arch Toxicol       Date:  2012-03-01       Impact factor: 5.153

Review 6.  Apoptosis and acute kidney injury.

Authors:  Andrea Havasi; Steven C Borkan
Journal:  Kidney Int       Date:  2011-05-11       Impact factor: 10.612

7.  Cyclic adenosine monophosphate-dependent vascular responses to purinergic agonists adenosine triphosphate and uridine triphosphate in the anesthetized mouse.

Authors:  Mrugeshkumar K Shah; Philip J Kadowitz
Journal:  J Cardiovasc Pharmacol       Date:  2002-01       Impact factor: 3.105

Review 8.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

Authors:  N Pabla; Z Dong
Journal:  Kidney Int       Date:  2008-02-13       Impact factor: 10.612

9.  New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.

Authors:  Gonzalo García; Isabel Serrano; Patricia Sánchez-Alonso; Manuel Rodríguez-Puyol; Ramón Alajarín; Mercedes Griera; Juan J Vaquero; Diego Rodríguez-Puyol; Julio Alvarez-Builla; María L Díez-Marqués
Journal:  Eur J Med Chem       Date:  2012-01-30       Impact factor: 6.514

Review 10.  Exploring the mechanisms of vascular smooth muscle tone with highly specific, membrane-permeable inhibitors of cyclic GMP-dependent protein kinase Ialpha.

Authors:  Wolfgang R G Dostmann; Werner Tegge; Ronald Frank; Christian K Nickl; Mark S Taylor; Joseph E Brayden
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.